Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

TANNERMEDICO A/S

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1% 1.1%   Bankruptcy risk   2.7% 2.2% 1.5% 1.0% 1.3% 2.1% 4.8% 4.8%   Credit score (0-100)   62 67 75 85 79 62 45 45   Credit rating   BBB BBB A A A A BBB BBB   Credit limit (kDKK)   0.0 0.2 17.7 351.0 90.0 0.5 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   508 1,197 2,163 2,462 3,808 3,106 0.0 0.0   EBITDA   95.0 -177 123 124 1,118 478 0.0 0.0   EBIT   -9.0 -300 -10.0 -25.0 969 281 0.0 0.0   Pre-tax profit (PTP)   -184.0 -165.0 34.0 499.0 476.0 76.8 0.0 0.0   Net earnings   -194.0 -165.0 102.0 389.0 371.0 59.8 0.0 0.0   Pre-tax profit without non-rec. items   -184 -165 34.0 499 476 76.8 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   5,300 5,135 5,229 5,617 5,989 6,048 4,609 4,609   Interest-bearing liabilities   3.0 332 606 418 58.0 675 0.0 0.0   Balance sheet total (assets)   5,717 5,653 6,963 6,865 6,939 9,182 4,609 4,609   Net Debt   -1,525 -1,268 -1,022 -1,235 -1,010 -245 -3,692 -3,692     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   508 1,197 2,163 2,462 3,808 3,106 0.0 0.0   Gross profit growth   0.0% 135.6% 80.7% 13.8% 54.7% -18.4% -100.0% 0.0%   Employees   2 2 3 3 3 2 0 0   Employee growth %   100.0% 0.0% 50.0% 0.0% 0.0% -33.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   5,717 5,653 6,963 6,865 6,939 9,182 4,609 4,609   Balance sheet change%   -1.1% -1.1% 23.2% -1.4% 1.1% 32.3% -49.8% 0.0%   Added value   95.0 -177.0 123.0 124.0 1,118.0 477.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -55 -95 -83 -298 -299 81 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -2.0 -3.0 -4.0 -5.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -1.8% -25.1% -0.5% -1.0% 25.4% 9.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   0.5% -2.7% 3.7% 8.6% 15.9% 6.7% 0.0% 0.0%   ROI %   0.6% -2.9% 4.2% 10.0% 17.9% 8.3% 0.0% 0.0%   ROE %   -3.6% -3.2% 2.0% 7.2% 6.4% 1.0% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   92.7% 90.8% 75.1% 81.8% 86.3% 65.9% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -1,605.3% 716.4% -830.9% -996.0% -90.3% -51.2% 0.0% 0.0%   Gearing %   0.1% 6.5% 11.6% 7.4% 1.0% 11.2% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   6,114.3% 6.0% 43.1% 18.6% 262.2% 126.7% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   10.3 7.9 2.9 3.8 5.9 2.0 0.0 0.0   Current Ratio   11.6 9.1 3.5 5.1 7.7 2.8 0.0 0.0   Cash and cash equivalent   1,528.0 1,600.0 1,628.0 1,653.0 1,068.0 919.1 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   3,919.0 3,587.0 3,420.0 3,409.0 4,514.0 4,516.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   48 -89 41 41 373 239 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   48 -89 41 41 373 239 0 0   EBIT / employee   -5 -150 -3 -8 323 141 0 0   Net earnings / employee   -97 -83 34 130 124 30 0 0